Blefaritis

Blepharitis is a common eye condition that causes inflammation, redness, swelling, and irritation along the edges of the eyelids—the thin rims of skin where the eyelashes grow. The word comes from the Greek word for eyelid (blepharon) and the suffix “-itis,” meaning inflammation. It is sometimes called lid margin disease. When the condition primarily affects the oil-producing glands inside the eyelid, it may also be referred to as meibomian gland dysfunction.

Blepharitis is not a single disease but an umbrella term for several related conditions that all cause eyelid margin inflammation. It is one of the most commonly seen eye conditions in clinical practice—surveys of U.S. ophthalmologists and optometrists have found that between 37 and 47% of patients seen in their offices show signs of blepharitis. It affects people of all ages and ethnic backgrounds. Blepharitis is not contagious, and in most cases, it does not permanently damage vision. However, it is a chronic condition—meaning it cannot be cured and tends to return—with flare-ups that come and go over time. With consistent daily care, most people can keep their symptoms well-controlled.

Doctors classify blepharitis by where on the eyelid the inflammation occurs. The two main types are anterior (front) and posterior (back) blepharitis, named for which part of the eyelid margin is most affected. Both types are often present at the same time—this overlap is called mixed blepharitis and is very common in practice.

• Anterior blepharitis: inflammation affecting the outer front edge of the eyelid, around the base of the eyelashes and the lash follicles. It is primarily caused by bacteria or mite overgrowth. There are three recognized subtypes. Staphylococcal blepharitis is caused by Staphylococcus aureus bacteria colonizing the eyelid margins. It tends to affect younger adults, is more common in women, and produces hard, crusty scales that wrap tightly around individual lash bases. Seborrheic blepharitis is linked to seborrheic dermatitis—a common skin condition causing flaking and oiliness—and produces greasier, softer scales with less redness than the Staphylococcal form. Demodex blepharitis is caused by an overgrowth of microscopic mites called Demodex folliculorum and Demodex brevis that normally live in hair follicles and skin glands in small numbers. When their population becomes too large, they cause chronic irritation. The hallmark sign is cylindrical dandruff—waxy, sleeve-like debris that wraps around the base of the eyelashes. Demodex blepharitis is found in a large proportion of patients with chronic blepharitis and becomes more common with age.
• Posterior blepharitis: inflammation affecting the inner edge of the eyelid, where the meibomian glands open onto the lid margin. The meibomian glands produce the oily outer layer of the tear film that slows tear evaporation. When these glands become blocked or dysfunctional—a condition called meibomian gland dysfunction (MGD)—the oil they produce thickens and clogs the gland openings. The result is an unstable tear film, faster evaporation, dry eye symptoms, and chronic lid inflammation. Posterior blepharitis is closely associated with rosacea, a chronic skin condition causing facial redness.
• Mixed blepharitis: Both anterior and posterior blepharitis are present at the same time. This is the most common pattern seen in clinical practice, as anterior and posterior causes frequently coexist and aggravate each other.
• Drug-induced blepharitis: Some systemic medications, including certain chemotherapy agents, can cause eyelid inflammation as a side effect. If blepharitis begins or worsens after starting a new medicine, it is worth discussing with the prescribing doctor.

Blepharitis develops when the normal balance of bacteria, mites, and oils on the eyelid surface is disrupted. The specific cause depends on the type. Anterior blepharitis is most often caused by an overgrowth of Staphylococcus aureus bacteria on the eyelid skin and lash follicles, by Demodex mites, or by the skin changes associated with seborrheic dermatitis. Posterior blepharitis is caused by dysfunction of the meibomian glands—the row of small oil-producing glands that run along the inner edge of each eyelid. When these glands are blocked or inflamed, they fail to produce the clear, free-flowing oil the tear film needs, leading to a cycle of eyelid inflammation and worsening dry eye.

In many people, multiple causes are active at the same time. Key contributing causes and mechanisms include:

• Bacterial overgrowth: Staphylococcus aureus colonizes the eyelid margins and releases toxins and enzymes that directly irritate the eyelid skin and lash follicles, causing redness, flaking, and eyelash changes.
• Demodex mite infestation: Microscopic mites that are a normal part of skin flora can multiply beyond healthy levels and block follicles, carry bacteria, and trigger chronic low-grade inflammation of the eyelid margins.
• Seborrheic dermatitis: This common skin condition causes oily flaking on the scalp, eyebrows, and eyelids. When it affects the eyelid margins, it disrupts the normal skin barrier and contributes to anterior blepharitis.
• Meibomian gland dysfunction: Blocked or inflamed meibomian glands produce thickened, cloudy oil or stop secreting adequately. This disrupts the tear film’s outer lipid layer and allows the eyelid margins to become chronically irritated and inflamed.
• Rosacea: This chronic skin condition causes abnormal blood vessel growth and inflammation in the face and eyelids. It is one of the most strongly associated systemic conditions with posterior blepharitis and meibomian gland dysfunction.
• Allergic reactions: Reactions to eye drops, contact lens solutions, cosmetics, or environmental allergens can cause or worsen eyelid inflammation.
• Hormonal changes: Androgens (hormones present in both men and women) regulate meibomian gland function. Hormonal changes related to aging, menopause, or certain medical conditions can reduce meibomian gland output and contribute to posterior blepharitis.

Blepharitis can affect anyone, but certain factors make it more likely to develop or more difficult to control once it has begun.

• Older age: The risk of blepharitis, particularly the Demodex and meibomian gland dysfunction forms, increases with age as gland function declines and mite populations naturally grow.
• Rosacea: People with rosacea are at high risk for posterior blepharitis. Managing rosacea is an important part of controlling the eyelid condition.
• Seborrheic dermatitis: Nearly all patients with seborrheic blepharitis also have seborrheic dermatitis on the scalp or face. Treating the skin condition usually helps the eyelids as well.
• Contact lens wear: Contact lenses can trap bacteria and debris against the eyelid margin and disrupt the tear film, increasing the risk of blepharitis and making existing blepharitis harder to manage.
• Dry eye disease: Blepharitis and dry eye are closely linked. Meibomian gland dysfunction is the most common cause of evaporative dry eye, and chronic dry eye in turn worsens eyelid inflammation. The two conditions perpetuate each other.
• Poor eyelid hygiene: Infrequent or ineffective cleaning of the eyelid margins allows bacteria, mites, and debris to accumulate, raising the risk of flare-ups.
• Diabetes mellitus: Diabetes is associated with changes in meibomian gland structure and function, as well as with a higher prevalence of skin conditions like seborrheic dermatitis.
• Use of certain medications: Some systemic drugs, including certain chemotherapy agents, can trigger or worsen blepharitis as a side effect.

There is no formal screening program for blepharitis. The condition is identified during routine eye exams when a doctor examines the eyelid margins under magnification. Because blepharitis is so common and because it contributes to dry eye disease, contact lens discomfort, and other surface conditions, eye doctors routinely assess the eyelid margins as part of any comprehensive eye examination. People who notice persistent eyelid redness, crusting, or irritation—especially first thing in the morning—should bring these symptoms to their doctor’s attention.

Blepharitis caused by seborrheic dermatitis or rosacea cannot be fully prevented, as these are underlying conditions that require ongoing management rather than cure. However, consistent habits can significantly reduce the frequency and severity of flare-ups. Preventative steps include:

• Practice regular eyelid hygiene: Gently cleaning the eyelid margins daily with a warm, damp cloth or commercially available eyelid wipes is the most important preventative step. This removes accumulated bacteria, mites, oils, and debris before they can cause inflammation.
• Apply warm compresses regularly: Warming the eyelids for five to ten minutes each day softens the oil inside the meibomian glands, helping it flow more freely and reducing the risk of blockage and posterior blepharitis.
• Remove eye makeup thoroughly each night: Makeup residue along the eyelid margins feeds bacteria and blocks meibomian gland openings. Complete removal each evening before sleep is important for anyone prone to blepharitis.
• Avoid rubbing the eyes: Eye rubbing can transfer bacteria and mites and aggravate already-inflamed eyelid tissue.
• Replace eye cosmetics regularly: Eye makeup, especially mascara and eyeliner, harbors bacteria and should be replaced every three months.
• Manage contributing skin conditions: Keeping rosacea and seborrheic dermatitis well controlled reduces their impact on the eyelids.
• Follow proper contact lens hygiene: Using fresh, properly cleaned lenses and appropriate lens solutions reduces the bacterial load on the eyelid margins.

The most characteristic feature of blepharitis is a persistent irritation and grittiness of the eyelids, typically worst first thing in the morning upon waking and improving somewhat as the day progresses. Symptoms tend to come and go over time and often worsen in dry, windy, or dusty conditions, during allergy seasons, or when eyelid hygiene is not maintained consistently. Both eyes are usually affected, though symptoms may be worse in one eye than the other.

Common signs and symptoms of blepharitis include:

• Eyelid redness and swelling: The eyelid margins appear red, irritated, and sometimes puffy, particularly along the lash line.
• Itching or burning of the eyelids: This can be a persistent sensation that may range from mild to very bothersome.
• Gritty or foreign body sensation: This is a feeling of sand or grit in the eye, caused by the disrupted tear film and surface irritation.
• Crusty or flaky debris at the base of the eyelashes: scales or crusts on or between the lashes that are typically most visible in the morning. Hard, collarette-type crusts suggest Staphylococcal or Demodex blepharitis; softer, oilier scales suggest seborrheic blepharitis.
• Sticky eyelids in the morning: The eyes may feel glued shut upon waking from overnight accumulation of discharge and dried secretions.
• Excessive tearing or watery eyes: Paradoxically, the disrupted tear film from meibomian gland dysfunction can cause reflex overproduction of watery tears.
• Dry, irritated eyes: This is particularly common with posterior blepharitis, where the damaged lipid layer of the tear film allows tears to evaporate too quickly.
• Sensitivity to light (photophobia): This happens particularly when the corneal surface is irritated.
• Blurred vision: This is usually mild and often clears temporarily with blinking as the tear film is briefly refreshed.
• Eyelash changes: Lashes may become misdirected (pointing toward the eye), grow in abnormal directions, or fall out in more severe or long-standing cases.
• Foam or frothy appearance at the inner corner of the eye: This is particularly associated with meibomian gland dysfunction, where the abnormal oil mixes with the tear film to create a soapy foam along the eyelid margin.
• Styes and chalazia: Recurrent styes (acute, painful bacterial infections of a lash follicle) or chalazia (firm, painless lumps from a blocked meibomian gland) are common complications of chronic blepharitis.

An ophthalmologist (a medical doctor specializing in eye disease) or an optometrist (a licensed eye care provider) diagnoses blepharitis. In most cases, the diagnosis is made through a clinical examination of the eyelids without the need for laboratory tests. When Demodex infestation is suspected, an eyelash can be examined under a microscope to confirm the presence of mites. The doctor will also assess whether blepharitis has caused or contributed to other conditions, such as dry eye, conjunctivitis, or corneal changes that need treatment in their own right.

• Slit-lamp examination: A specialized microscope with a bright beam of light gives the doctor a magnified, detailed view of the eyelid margins, lash follicles, meibomian gland openings, conjunctival surface, and cornea. The doctor looks for redness and thickening of the lid margin, the pattern and type of scaling or crusting, plugged or capped meibomian gland openings, foam in the tear film, and any corneal changes. This is the primary diagnostic tool for blepharitis.
• Eyelid margin assessment: The doctor examines the quality and quantity of meibomian gland secretions by gently pressing on the eyelid margin and observing whether clear, free-flowing oil is expressed or whether the output is cloudy, thick, or absent.
• Meibography: Infrared imaging of the eyelids can show the internal structure of the meibomian glands and reveal gland dropout (permanent structural loss of gland tissue) in patients with advanced posterior blepharitis. This helps assess severity and guide treatment expectations.
• Eyelash microscopy: When cylindrical dandruff (waxy sleeve-like debris at the lash base) is seen during examination, an eyelash can be gently removed and examined under a light microscope to confirm the presence and density of Demodex mites. This is particularly useful for determining whether Demodex-specific treatment is needed.
• Tear film and dry eye tests: Because blepharitis and dry eye disease so frequently coexist, the doctor will often assess tear film stability (tear break-up time), the degree of corneal and conjunctival staining, and tear production (Schirmer test) as part of the same visit. These tests guide the overall treatment plan.
• Bacterial culture: Occasionally, a swab of the eyelid margin is sent to a laboratory to identify the specific bacteria involved. This is most useful in cases that have not responded to standard antibiotic treatment, or when an unusual or resistant organism is suspected.

Blepharitis cannot be cured, but it can be managed very effectively. The core of treatment for all types of blepharitis is consistent daily eyelid hygiene—without this foundation, other treatments provide only temporary relief. Your doctor will add prescription medicines, in-office procedures, or treatments for linked conditions based on how severe your blepharitis is and which type you have. Most people with blepharitis need to continue some level of eyelid care indefinitely to prevent flare-ups, even during periods when symptoms are well controlled.

Warm compresses and eyelid cleaning are the essential first steps for everyone with blepharitis. Applying a warm, damp cloth over closed eyelids for five to ten minutes each day softens the oils inside the meibomian glands and loosens crusts and debris on the lash margins. Immediately after the warm compress, the eyelid margins should be gently cleaned. This can be done with a clean washcloth, cotton pad moistened with warm water, or commercially available eyelid scrub wipes and foams (such as OCuSOFT® Lid Scrub or Cliradex®, which contains tea tree oil and is particularly effective against Demodex mites). Gentle scrubbing along the lash line removes bacteria, mite eggs, biofilm, and dried secretions. Lid hygiene is most effective when done every day as a habit, not only during flare-ups. Preservative-free artificial tears used several times daily help relieve the dry eye symptoms that nearly always accompany blepharitis and are an important part of the daily routine.

When eyelid hygiene alone is not sufficient to control symptoms, your doctor may prescribe one or more of the following treatments. For anterior blepharitis with significant bacterial colonization, a short course of topical antibiotic ointment—such as bacitracin or erythromycin—applied to the eyelid margins at bedtime can reduce the bacterial load and ease acute flare-ups. Oral doxycycline (a low-dose antibiotic taken by mouth) is used for moderate-to-severe blepharitis, particularly when rosacea or significant meibomian gland dysfunction is involved. At low doses, doxycycline works not primarily as an antibiotic but as an anti-inflammatory agent that improves meibomian gland secretion quality over several weeks to months. This is typically continued for three to six months. For Demodex blepharitis, lotilaner ophthalmic solution 0.25% (Xdemvy®) is the first U.S. Food and Drug Administration (FDA)-approved treatment specifically targeting Demodex mites—approved in 2023. It is applied twice daily for six weeks and has been shown in clinical trials to significantly reduce mite density and eyelid inflammation. Tea tree oil-based lid scrubs and in-office treatments are also used for Demodex, though they are not FDA-approved medications. Short courses of topical corticosteroid eye drops or ointment may be prescribed for acute flares with significant inflammation, but long-term steroid use is avoided because of the risks of elevated eye pressure and cataract formation. When dry eye associated with blepharitis is moderate or severe, prescription anti-inflammatory drops such as cyclosporine (Restasis® or Cequa®) or lifitegrast (Xiidra®) may be added to address the underlying ocular surface inflammation. In-office thermal pulsation procedures (such as LipiFlow®) can unclog blocked meibomian glands and improve gland function in patients with significant posterior blepharitis who have not responded adequately to warm compresses alone. Intense pulsed light (IPL) therapy applied around the eyelids reduces abnormal blood vessel activity and improves meibomian gland function, particularly in patients with rosacea-associated blepharitis.

Living with blepharitis means accepting that this is a condition you manage rather than one you cure. The good news is that most people with blepharitis, even those with the chronic and recurring form, can keep their symptoms at a comfortable, manageable level with the right daily routine. Warm compresses and eyelid cleaning are simple habits that take only a few minutes each morning and make a meaningful difference. Staying consistent—even on days when symptoms are mild—is the key to preventing flare-ups rather than just reacting to them. If you wear contact lenses, work with your eye doctor to find a management approach that keeps both your eyelids and your lenses comfortable. If rosacea or seborrheic dermatitis is contributing to your blepharitis, treating those skin conditions consistently will benefit your eyes as well. Call your doctor if symptoms worsen significantly, if you develop a painful lump or stye on the eyelid, if your vision changes, or if treatments that previously worked stop helping—these may signal a need to adjust your care plan.

To further your understanding of your diagnosis and to contribute to cutting-edge research, consider participating in a clinical trial so clinicians and scientists can learn more about causes, symptoms, treatment, and prevention of blepharitis and related disorders. Clinical research uses human volunteers to help researchers learn more about a disorder and perhaps find better ways to safely detect, treat, or prevent disease.

All types of volunteers are needed—those who are healthy or may have an illness or disease—of all different ages, sexes, races, and ethnicities to ensure that study results apply to as many people as possible, and that treatments will be safe and effective for everyone who will use them.

To learn more about clinical trials and find studies that may be right for you, visit National Institutes of Health (NIH) Clinical Research Trials and You and ClinicalTrials.gov to search active studies by condition, location, and age group.